Farm Maria, Antovic Aleksandra, Schmidt David E, Bark Niklas, Soutari Nida, Siddiqui Anwar J, Holmström Margareta, Pruner Iva, Antovic Jovan P
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
TH Open. 2020 Aug 20;4(3):e178-e188. doi: 10.1055/s-0040-1714210. eCollection 2020 Jul.
For acute venous thromboembolism (VTE), a biomarker with higher specificity than D-dimer would be of great clinical use. Thrombin generation and overall hemostatic potential (OHP) reflect the hemostatic balance by globally assessing multiple coagulation factors and inhibitors. These tests discriminate between healthy controls and patients with a prothrombotic tendency but have yet to be established as clinical biomarkers of VTE. This study compares endogenous thrombin potential (ETP) and OHP to D-dimer and fibrin monomers (FM) in outpatients with suspected VTE. A cross-sectional diagnostic study where 954 patients with suspected pulmonary embolism or deep venous thrombosis were recruited consecutively from the medical emergency department at Karolinska University Hospital. D-dimer, FM, OHP, and ETP were analyzed in a subpopulation of 60 patients with VTE and 98 matched controls without VTE. VTE was verified either by ultrasonography or computed tomography and clinical data were collected from medical records. Compared with healthy controls, both VTE and non-VTE patients displayed prothrombotic profiles in OHP and ETP. D-dimer, FM, ETP area under the curve (AUC), and ETP T were significantly different between patients with VTE and non-VTE. The largest receiver-operating characteristic AUCs for discrimination between VTE and non-VTE, were found in D-dimer with 0.94, FM 0.77, and ETP AUC 0.65. No useful cutoff could be identified for the ETP or the OHP assay. Compared with D-dimer, neither ETP nor OHP were clinically viable biomarkers of acute venous thrombosis. The data indicated that a large portion of the emergency patients with suspected VTE were in a prothrombotic state.
对于急性静脉血栓栓塞症(VTE),一种比D - 二聚体具有更高特异性的生物标志物将具有重大临床应用价值。凝血酶生成和整体止血潜力(OHP)通过全面评估多种凝血因子和抑制剂来反映止血平衡。这些检测能够区分健康对照者和具有血栓形成倾向的患者,但尚未被确立为VTE的临床生物标志物。 本研究比较了疑似VTE门诊患者的内源性凝血酶潜力(ETP)和OHP与D - 二聚体及纤维蛋白单体(FM)。 一项横断面诊断研究,从卡罗林斯卡大学医院急诊科连续招募了954例疑似肺栓塞或深静脉血栓形成的患者。在60例VTE患者和98例匹配的无VTE对照者的亚组中分析了D - 二聚体、FM、OHP和ETP。通过超声或计算机断层扫描验证VTE,并从病历中收集临床数据。 与健康对照者相比,VTE患者和非VTE患者在OHP和ETP方面均表现出血栓形成倾向。VTE患者和非VTE患者之间的D - 二聚体、FM、ETP曲线下面积(AUC)和ETP T存在显著差异。在区分VTE和非VTE方面,最大的受试者工作特征AUC分别为:D - 二聚体0.94、FM 0.77和ETP AUC 0.65。未发现ETP或OHP检测的有效临界值。 与D - 二聚体相比,ETP和OHP均不是急性静脉血栓形成的临床可行生物标志物。数据表明大部分疑似VTE的急诊患者处于血栓形成前状态。